MedTrace Logo

Evaluating the Shared Decision Making Process Scale in Cancer Screening Decisions

NCT04601272 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 240

Last updated 2023-03-30

Study results available
· View outcomes & findings →

Summary

The purpose of this retrospective observational study is to evaluate the performance of the Shared Decision Making Process scale in a sample of patients who have received a decision aid about the decision to screen or not screen for breast cancer, colon cancer, prostate cancer, or lung cancer.

Conditions

  • Breast Cancer Screening
  • Colon Cancer Screening
  • Prostate Cancer Screening

Interventions

BEHAVIORAL

Decision aid

Healthwise patient decision aids for breast, prostate, colon and lung cancer screening provide information on the pros and cons of cancer screening and guidance in process of selecting a choice.

Sponsors & Collaborators

  • Agency for Healthcare Research and Quality (AHRQ)

    collaborator FED

  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Karen R Sepucha, PhD · Massachusetts General Hospital

Eligibility

Min Age
35 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-09-29
Primary Completion
2021-04-16
Completion
2021-06-24

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04601272 on ClinicalTrials.gov